Roy D. Baynes, Director: Travere Therapeutics TVTX Sell · Filed 05/04

Trade details

Type: Insider sale
Amount: $431,145
Shares · price: 9,750 sh · $44.22 a share
Held after: 37,500 sh
Stock: Travere Therapeutics TVTX
Person: Roy D. BaynesDirector
Trade date: 26/05/01
Filed: 26/05/04
Days to filing: 3 days

Sold 20.6% of holdings

Share of holding sold: 20.6%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 04/01~05/31

Roy D. Baynes's recent trades

Roy D. BaynesDirector
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$225K
4,500 sh
$225K
Filed 06/16
Traded 06/12
Roy D. BaynesDirector
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$225K
4,500 sh
$225K
Filed 06/12
Traded 06/12
Roy D. BaynesDirector
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$209.9K
4,500 sh
$209.9K
Filed 05/06
Traded 05/05
Roy D. BaynesDirector
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$209.9K
4,500 sh
$209.9K
Filed 05/05
Traded 05/05
Roy D. BaynesDirector
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$431.1K
9,750 sh
$431.1K
Filed 05/01
Traded 05/01